Determining the Required Training Capacity Within a Military Establishment.

SN Comput Sci

Director General Military Personnel Research and Analysis, Department of National Defence, 101 Colonel By Drive, Ottawa, Canada.

Published: April 2022

We address the problem of deciding how many positions to set aside for military recruits undergoing training. Within a cap on the total number of military members, we vary the ratio between positions allocated to the training pipeline versus those required in the trained effective establishment. This is done with the goal of determining the extent to which given ratios are sustainable. We use a Markovian model of the training pipeline, with parameters derived from historical personnel data. Through Monte Carlo simulation, we predict how often a given ratio allows the required trained force to be fully generated, as well as the surplus of trained personnel, it is expected to generate. We extend our previous work in this area by considering an alternative Human Resources policy that uncaps the training pipeline. Our modelling results have informed ongoing initiatives to optimize the force mix and structure of the Canadian Armed Forces.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040354PMC
http://dx.doi.org/10.1007/s42979-022-01122-zDOI Listing

Publication Analysis

Top Keywords

training pipeline
12
required trained
8
training
5
determining required
4
required training
4
training capacity
4
capacity military
4
military establishment
4
establishment address
4
address problem
4

Similar Publications

NetSDR: Drug repurposing for cancers based on subtype-specific network modularization and perturbation analysis.

Biochim Biophys Acta Mol Basis Dis

January 2025

MOE Key Laboratory of Geriatric Diseases and Immunology, Suzhou Key Laboratory of Pathogen Bioscience and Anti-infective Medicine, Department of Bioinformatics and Computational Biology, School of Life Sciences, Suzhou Medical College of Soochow University, Suzhou 215123, China; Jiangsu Province Engineering Research Center of Precision Diagnostics and Therapeutics Development, Soochow University, Suzhou 215123, China; Key Laboratory of Alkene-carbon Fibres-based Technology & Application for Detection of Major Infectious Diseases, Soochow University, Suzhou 215123, China; Jiangsu Key Laboratory of Infection and Immunity, Soochow University, Suzhou 215123, China. Electronic address:

Cancer, a heterogeneous disease, presents significant challenges for drug development due to its complex etiology. Drug repurposing, particularly through network medicine approaches, offers a promising avenue for cancer treatment by analyzing how drugs influence cellular networks on a systemic scale. The advent of large-scale proteomics data provides new opportunities to elucidate regulatory mechanisms specific to cancer subtypes.

View Article and Find Full Text PDF

Challenges and compromises: Predicting unbound antibody structures with deep learning.

Curr Opin Struct Biol

January 2025

Oxford Protein Informatics Group, Department of Statistics, University of Oxford, 24-29 St Giles', Oxford, OX1 3LB, United Kingdom.

Therapeutic antibodies are manufactured, stored and administered in the free state; this makes understanding the unbound form key to designing and improving development pipelines. Prediction of unbound antibodies is challenging, specifically modelling of the CDRH3 loop, where inaccuracies are potentially worse due to a bias in structural data towards antibody-antigen complexes. This class imbalance provides a challenge for deep learning models trained on this data, potentially limiting generalisation to unbound forms.

View Article and Find Full Text PDF

AVP-GPT2: A Transformer-Powered Platform for De Novo Generation, Screening, and Explanation of Antiviral Peptides.

Viruses

December 2024

Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd., Beijing 100176, China.

Human respiratory syncytial virus (RSV) remains a significant global health threat, particularly for vulnerable populations. Despite extensive research, effective antiviral therapies are still limited. To address this urgent need, we present AVP-GPT2, a deep-learning model that significantly outperforms its predecessor, AVP-GPT, in designing and screening antiviral peptides.

View Article and Find Full Text PDF

Aurora kinase B (AurB) is a pivotal regulator of mitosis, making it a compelling target for cancer therapy. Despite significant advances in protein kinase inhibitor development, there are currently no AurB inhibitors readily available for therapeutic use. This study introduces a machine learning-assisted drug repurposing framework integrating quantitative structure-activity relationship (QSAR) modeling, molecular fingerprints-based classification, molecular docking, and molecular dynamics (MD) simulations.

View Article and Find Full Text PDF

Artificial intelligence (AI) technologies have been widely applied to the automated detection of pipeline leaks. However, traditional AI methods still face significant challenges in effectively detecting the complete leak process. Furthermore, the deployment cost of such models has increased substantially due to the use of GPU-trained neural networks in recent years.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!